Connect with us

Press Releases

Essilor Receives FDA ‘Breakthrough Device’ Designation for Stellest

The designation builds on results of a clinical trial in China.




(PRESS RELEASE) CHARENTON-LE-PONT — Essilor announced that the U.S. Food and Drug Administration (FDA) has granted “Breakthrough Device” designation to its Essilor Stellest spectacle lens, the Company’s new generation lens developed to correct myopia and slow down the progression of myopia in children.

The designation of the Essilor’s Stellest spectacle lens as a “Breakthrough Device” by the FDA, that will lead to further U.S. research and FDA review, builds on the publication of ground-breaking two-year results of an ongoing three-year clinical trial, in China, in myopic children. After the first year, the trial results demonstrated that the eye growth of 9 out of 10 children wearing the Essilor Stellest lens was similar or slower than non-myopic children. While after two years, Essilor Stellest lens has been proven to be among the most effective myopia control solutions which have ever been tested.

“The “Breakthrough Device” designation for our Essilor Stellest lens is a great achievement and an illustration of its potential in slowing down the progression of myopia in children. This designation represents an important milestone in our fight against the myopia pandemic. We look forward to working closely with the FDA for further clinical study and review, so we can provide the benefit of Essilor Stellest to U.S. children who continue to be at risk of vision threatening complications due to high myopia.” commented Norbert Gorny, chief operating officer and Chief Research & Development Officer of Essilor International.

The Breakthrough Devices Program by the FDA is intended to provide patients and health care professionals with timely access to medical devices that offer more effective treatment or diagnosis of life-threatening or irreversibly debilitating diseases or conditions by speeding up their development, assessment, and review.

After successful launch in China and other countries since 2020 with extremely positive response from eye care professionals, Essilor intends to further roll out Essilor Stellest in other countries.

For more information, clickt here.




The Best Overall Progressive Lens, Now Powered by AI

Engineered with Behavioral Artificial Intelligence and utilizing new XR-motion™ technology, Varilux XR series goes beyond prescription and eye physiology to consider the patient’s visual behavior and design a progressive lens that respects how
their eyes naturally move.

Varilux XR series comes in two versions, Varilux® XR design and Varilux® XR track. The Varilux XR track lens provides an additional level of personalization by incorporating the exclusive Near Vision Behavior Measurement, providing up to 25% more near vision width3 according to the patient’s need, so patients get the highest level of customization.

Discover Varilux XR series and enjoy instantly sharp vision in motion4 and seamless transitions from near to far.

For more information, visit here.

Promoted Headlines





Get the most important news and business ideas for eyecare professionals every weekday from INVISION.



Most Popular